We are live on ! Find out more
RNAM

Avidity Biosciences

Delisted

RNAM was delisted on the 26th of February, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$147M +$4.31M +253,689 +3%
RI
2
RTW Investments
New York
$88.6M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$70.4M +$584K +34,391 +0.9%
BlackRock
4
BlackRock
New York
$60.3M -$535K -31,471 -1%
EC
5
EcoR1 Capital
California
$51M
Federated Hermes
6
Federated Hermes
Pennsylvania
$45.7M
Vanguard Group
7
Vanguard Group
Pennsylvania
$42.5M +$5.01M +294,791 +15%
RCM
8
RA Capital Management
Massachusetts
$40M +$29.6M +1,743,775 +412%
APM
9
Avidity Partners Management
Texas
$37.8M +$3.91M +230,000 +13%
CAM
10
Cormorant Asset Management
Massachusetts
$37.2M
State Street
11
State Street
Massachusetts
$30.3M +$4.15M +244,464 +17%
ACA
12
Avoro Capital Advisors
New York
$24M +$1.19M +70,000 +6%
Wellington Management Group
13
Wellington Management Group
Massachusetts
$21M +$1.9M +112,024 +11%
BC
14
Boxer Capital
California
$20.7M
ACM
15
Alethea Capital Management
Washington
$16.4M +$7.13K +420 +0%
Alkeon Capital Management
16
Alkeon Capital Management
New York
$15.8M
Geode Capital Management
17
Geode Capital Management
Massachusetts
$13.6M +$388K +22,855 +3%
GPP
18
Great Point Partners
Connecticut
$9.23M
5VM
19
5AM Venture Management
California
$7.21M
Northern Trust
20
Northern Trust
Illinois
$6.9M -$99.3K -5,847 -2%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$6.88M +$2.95M +173,365 +87%
OCA
22
Octagon Capital Advisors
New York
$5.94M -$2.12M -125,000 -28%
Charles Schwab
23
Charles Schwab
California
$5.54M +$144K +8,461 +3%
Marshall Wace
24
Marshall Wace
United Kingdom
$4.89M
AG
25
Artal Group
Luxembourg
$4.62M